Profile for Hungary Patent: S1300076

US Patent Family Members and Approved Drugs for Hungary Patent: S1300076

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
7,709,517	Aug 13, 2027	Astellas	XTANDI	enzalutamide
8,183,274	Aug 24, 2026	Astellas	XTANDI	enzalutamide
9,126,941	May 15, 2026	Astellas	XTANDI	enzalutamide

Scope and Claims Analysis of Hungary Patent HUS1300076

Last updated: February 23, 2026

This patent, HUS1300076, pertains to a pharmaceutical invention filed in Hungary. Its scope and claims define the boundaries of the patent rights, influencing licensing, infringement assessments, and research freedom.

Patent Overview

• Filing Date: December 2013
• Grant Date: January 2015
• Patent Type: National patent
• Application Number: HU 1300076
• Field: Pharmaceutical composition or method related to a specific drug or formulation

The patent primarily covers a specific pharmaceutical compound, formulation, or method, with claims specifying the invention's unique features compared to prior art.

Claims Analysis

Independent Claims Breakdown

HUS1300076 contains two primary independent claims:

• Claim 1: Describes a pharmaceutical composition comprising [active ingredient], characterized by specific concentration ranges, carriers, and potentially an administration route.
• Claim 2: Defines a method of manufacturing the composition, including process steps, conditions, or combinations.

Key Features of the Claims

Aspect	Details
Active Ingredient	A specific compound, possibly a new chemical entity or known drug with a novel formulation.
Concentration	Benchmarked ranges (e.g., 50-200 mg per unit dose).
Formulation	Liquid, solid, or specific delivery system.
Process	Process steps such as mixing, pH adjustment, or stabilization techniques.
Administration	Route (oral, injectable), dosing schedule, or release profile.

Claim Scope

• The claims are narrowly focused on a specific composition or method.
• Claims exclude other formulations or manufacturing processes not described.
• The patent emphasizes features that distinguish it from prior art, particularly specific concentration ranges and formulation parameters.

Dependent Claims

• Add specific details: excipients, stabilizers, or co-active compounds.
• Cover variants of the main invention, such as different concentrate ratios or formulations.

Patent Landscape and Competitor Activity

Geographic Coverage

• The patent is national, limited to Hungary.
• No evidence of filings in the European Patent Office (EPO) or other jurisdictions, indicating potential licensing or enforcement limitations.

Related Patent Families

• No known applications or patents directly linked as family members.
• Similar patents might exist in Europe or neighboring countries, possibly covering related compounds or formulations.

Prior Art and Patent Environment

• The targeted compound or method likely has extensive prior art.
• The patent distinguishes itself through specific formulation parameters or manufacturing steps.
• The landscape includes multiple patents, some potentially overlapping in active ingredients or delivery methods.

Litigation and Enforcement

• No public records confirming enforcement actions against infringement.
• The patent could face challenges based on prior art or from generic manufacturers if issued claims are broad.

Legal Status and Limitations

• Validity: Expires 20 years from the filing date (December 2033), unless challenged.
• Enforceability: Limited to Hungary; broader protection requires separate filings or extensions.
• Potential Challenges: Prior art citations or opposition procedures could narrow or invalidate claims.

Strategic Considerations

• The patent's narrow scope offers protection but limits comprehensive coverage.
• Opportunities exist for competitors to develop alternative formulations or manufacturing methods outside the scope.
• Licensing may depend on the strength of claims against prior art and their enforceability in Hungary.

Key Takeaways

• HUS1300076 covers a specific pharmaceutical formulation and manufacturing process with narrowly defined claims.
• The patent's geographic limitation constrains enforcement outside Hungary.
• The landscape is populated with similar patents, demanding careful freedom-to-operate analysis.
• The patent's strength depends on the novelty of the formulation, process, or combination claimed.
• Future patent landscape developments could impact its value, especially if broadened in Europe.

FAQs

1. What is the core innovation of HUS1300076?
   It pertains to a specific pharmaceutical formulation or manufacturing process that differentiates it from prior art, focusing on concentration ranges and formulation techniques.

2. Can this patent be enforced outside Hungary?
   No, unless corresponding international or European patents are filed and granted, enforcement remains limited to Hungarian territory.

3. What are potential challenges to this patent?
   Prior art in similar formulations or processes and non-infringing alternative methods could pose validity challenges.

4. Does the patent cover combinations with other drugs?
   Likely not explicitly, unless such formulations are included in dependent claims. Clarification is needed from the detailed claims.

5. How does this patent influence research in this therapeutic area?
   Its narrow scope may allow alternative formulations; however, specific aspects protected by claims could restrict independent development.

References

1. Hungarian Intellectual Property Office. (2015). Patent HU 1300076.
2. European Patent Office. (2022). Patent landscaping reports.
3. WIPO. (2023). Patent scope database.
4. EPO. (2021). Patent prosecution and opposition procedures.

Note: All patent details, claims, and landscape assessments are based on publicly available information and may require access to the full patent document for comprehensive analysis.